JENA, GERMANY (Press Release) - November 19, 2012 -
Extremely large benign prostatic hyperplasia treated successfully with biolitec®´s prostate-laser system LIFE™ – 70-year-old man with 10cm large prostate treated with success in Cairo, Egypt with Ceralas® HPD Dual-laser using TWISTER™-fibre – innovative biolitec® laser is the first urologic laser worldwide with two parallel wavelengths – more information on www.biolitec.de and www.infoprostata.de
Half of all men suffer from a benign enlargement of the prostate, the benign prostatic hyperplasia (BPH) in the second half of their lives. Symptoms of such a prostate disease are amongst others a weakened urine stream or an extended time for emptying the bladder. This leads to limitations in daily life, and the night’s sleep is disturbed.
In September 2012, Prof. Hassan Shaker from Cairo treated the largest prostate in his career with biolitec®´s LIFE™-laser system. The patient, a 70-year-old man, suffered from heavy discomfort of his prostate. The ultrasonic of the pelvis and stomach showed that the prostate had the size of 458ml (larger than an orange), and the transrectal ultrasound measured 402ml. “The medial lope protruded into the bladder and covered nearly half of the rear wall. I haven´t been able to visualize the ureter until the whole treatment was over”, said Prof. Shaker. The intervention took two hours and Prof. Shaker treated solely at 400 Watt. The whole procedure was completed with nearly no bleeding. The postoperative phase also proceeded smoothly and the patient was sent home the following day. Also, the catheter was removed after 48 hours. Now the patient can empty his bladder without any pain or other problems.
By European standards, such an enlargement of the prostate is rather unusual. Normally, a man’s prostate has the size of a chestnut or walnut, so that the patient is usually treated much quicker in case of a benign enlargement of the prostate.
During the treatment with biolitec®’s laser system, Selective Light Vaporization (SLV) is applied to gently remove the excessive tissue. The Ceralas® HPD Dual is the first urologic laser worldwide with two parallel wavelengths of 1470nm and 980nm. In combination with the new, patented TWISTER™-fibre, the LIFE™-laser system guarantees only minimal or no intra- or postoperative bleedings as well as protection of the surrounding tissue in favour of a fast convalescence. The laser achieves high ablation rates of 3 gramm/minute while keeping a low but effective coagulation zone to minimize the risk of possible side effects. Besides, it is possible to work in the contact mode.
Due to its high absorption in water, the LIFE™-laser systems avoid accidently firing into the bladder and other unintentional areas. The therapy can be applied on an outpatient basis and provides gentle healing. Furthermore, an ideal care of risk patients is possible. In comparison to conventional surgeries, the laser treatment of a benign prostatic hyperplasia is a less traumatising, almost painless and convenient alternative.
About biolitec®:
biolitec® AG is one of the leading companies worldwide in the field of medical laser treatments und the only provider that possesses all relevant core competencies – photosensitizers, laser devices and optical fibres – in the field of photodynamic therapy (PDT). Besides the laser treatment of cancer with Foscan®, biolitec® primarily researches on minimally-invasive and gentle laser treatments and markets them. ELVeS Radial™ (Endo Laser Vein System) the laser system is most often used worldwide for the treatment of varicose veins. Ceralas® HPD laser therapy enables a gentle treatment of e.g. benign prostatic hyperplasia (BPH) in urology. Gentle laser treatments in the fields of proctology, ENT, orthopaedics, gynaecology as well as ophtalmology also belong to the business field of biolitec®. biolitec® is listed in the Prime Standard (ISIN DE0005213409). Further information at www.biolitec.com.
Press Contact:
Jörn Gleisner
Telefon: +49 (0) 6172/27159-20
Telefax: +49 (0) 6172/27159-69
E-Mail:
[ PRESS RELEASE ]
